SK BIOPHARMACEUTICALS revenue breakdown overview

SK BIOPHARMACEUTICALS revenue for the last year amounted to 547.60 B KRW, the most of which — 547.60 B KRW — came from its highest performing source at the moment, New Drugs, the year earlier bringing 354.89 B KRW. The greatest contribution to the revenue figure was made by United States — last year it brought SK BIOPHARMACEUTICALS 667.82 B KRW, and the year before that — 508.89 B KRW.